Bambusa Therapeutics, Inc. director Helmut Wolfgang Jeggle adds $6M of BBTX stock
After the purchase, the filing lists 9,264,301 shares held.
A director at Bambusa Therapeutics, Inc., Helmut Wolfgang Jeggle, purchased 375,000 shares of the company's stock on the open market on Nov 2. The purchase, at an average of $16.00 a share, comes to about $6 million.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 9,264,301 shares held.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Bambusa Therapeutics, Inc. (BBTX) |
|---|---|
| Insider | Helmut Wolfgang Jeggle |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 375,000 |
| Average price | $16.00 |
| Value | $6,000,000 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 2, 2026, 4:06 PM ET |
| Shares held after | 9,264,301 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
See all the latest insider trades · Browse the latest insider buying
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
